At the 44th Annual J.P. Morgan Healthcare Conference, McKesson’s CEO Brian Tyler underscored the company’s role as a diversified health care services leader. He emphasized McKesson’s commitment to providing scalable platforms that serve every segment of the healthcare ecosystem, including pharmacies, providers, biopharma manufacturers, payers and patients. Tyler opened with a reminder that detailed forward-looking statements and non-GAAP disclosures can be found on the McKesson website and in the slide deck behind him.

McKesson distributes approximately 33% of all pharmaceuticals across North America every day, leveraging its supply-chain infrastructure to fulfill orders for over 50,000 pharmacies. The company also connects into the daily workflow of more than 1 million healthcare providers through integrated software and logistics solutions, supporting end-to-end medication management and ordering processes.

Through its US Oncology Network managed services organization (USON MSO), McKesson projects that it will touch over 20% of all cancer patients in the United States this year. The MSO provides practice management, clinical support and technology platforms to community oncology practices, enabling standardized care pathways and improved patient outcomes in one of the fastest-growing segments of health services.

Brian Tyler highlighted McKesson’s approximately 40,000 employees as a core asset in driving operational efficiency and customer service excellence. He outlined strategic priorities for fiscal 2026, including further automation of core distribution centers, expansion of digital health offerings and selective acquisitions to bolster specialty pharmaceutical services and support evolving biopharma commercialization models.